Revision history of "NTproANP quantities throughout peripheral and cardiovascular blood flow"

Jump to navigation Jump to search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • curprev 18:39, 21 October 2024‎ Movesilk5 talk contribs‎ 7,072 bytes +7,072‎ Created page with "The median treatment period was 19 weeks (range 1-65), an average of 11 doses (range 1-36) were applied. 39 (45.3%) patients developed adverse events, mostly mild, grade I (64..."
Retrieved from "https://stairways.wiki/wiki/NTproANP_quantities_throughout_peripheral_and_cardiovascular_blood_flow"